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Background: - The association of end-stage renal disease (ESRD) and coronary artery calcification (CAC) is well known, but it is unclear how 
traditional risk factors contribute to coronary plaque burden in this high risk population. The aim of this study is to identify which clinical parameters 
best correlate with CAC among patients with ESRD.
methods: - The PACE study is a prospective cohort study to investigate sudden cardiac death among ESRD patients in hemodialysis. Patients 
enrolled in the study had a baseline CAC assessment and were stratified as follow: 0 - no calcium; 1-99 - mild disease; 100-399 - moderate 
disease; ≥400 - severe disease. Clinical predictors (age, gender, race, body-mass index [BMI], smoking history, hypertension, diabetes, personal and 
family history of coronary artery disease [CAD]) were analyzed among different CAC strata using analysis of variance. Multivariable logistic regression 
was used to determine the association between each factor and severe disease (CAC≥400). .
results: - A total of 201 patients (mean age 55.2±13.4 years, 113 men) were included in the analysis, with a median CAC 19 (IQR 0, 380). Age, 
personal and family history of CAD were associated to higher CAC levels, while being African-American was associated to lower levels of CAC (Table 1).
conclusions: - Although ESRD is a condition that leads to high CAC levels, additional risk stratification for CAD using clinical information is 
necessary. However, traditional risk factors can play a different role in this population.
Table 1 - Association of traditional clinical parameters with different CAC levels (n = 201)
No disease
(CAC = 0)
n = 77
Mild disease
(CAC - 1-99)
n = 43
Moderate disease
(CAC - 100-399)
n = 29
Severe disease
(CAC ≥ 400)
n = 52
p
Odds Ratio
(CAC ≥400)
Adjusted
Odds Ratio
(CAC >400)
Age (years) 46.8±13.0 54.7±11.0 59.9±11.9 62.9±11.4 <0.0001 2.5 (1.8 - 3.7)
Male gender 42 (55%) 20 (47%) 17 (59%) 34 (65%) 0.32 1.4 (0.8 - 2.8)
Race (African-American) 67 (87%) 33 (77%) 19 (66%) 27 (52%) <0.0001 0.3 (0.2 - 0.6) 0.4 (0.2-0.8)
BMI (Kg/m2) 29.6±7.4 27.4±8.0 28.6±6.9 26.8±5.6 0.096 0.7 (0.5 - 1.0) 0.7(0.5 - 1.0)
Hypertension 75 (97%) 42 (98%) 29 (100%) 51 (98%) 0.84 1.0 (0.1 - 9.8) 1.6 (0.1-28.5)
Diabetes 39 (51%) 19 (44%) 15 (52%) 32 (62%) 0.17 1.7 (0.9 - 3.1) 1.9 (0.9-3.9)
Smoking 41 (53%) 23 (53%) 22 (76%) 34 (65%) 0.11 1.4 (0.7 - 2.6) 1.2 (0.6-2.4)
Hx. of CAD 13 (17%) 7 (16%) 8 (28%) 22 (42%) 0.0086 2.5 (1.3 - 4.8) 1.4 (0.7-2.9
Fam. Hx. CAD 22 (29%) 12 (28%) 16 (55%) 29 (56%) 0.004 2.2 (1.2 - 4.0) 2.7 (1.3-5.6)
